Table 2. Cox regression analysis of nuclear APE1 expression on OS in invasive breast cancer defined by the Ki-67 low-level expression cohort.
Characteristic | OS (n = 151) | ||||
n | HR | 95% CI | p-value | ||
Age (years) | 0.174–2.516 | 0.543 | |||
<50 | 72 | 1 | |||
≥50 | 65 | 0.661 | |||
T stage | 0.824–21.996 | 0.084 | |||
T1-T2 | 130 | 1 | |||
T3-T4 | 7 | 4.258 | |||
Lymph node metastasis | 0.196–2.876 | 0.675 | |||
Negative | 92 | 1 | |||
Positive | 45 | 0.750 | |||
Estrogen receptor | 0.262–25.453 | 0.416 | |||
Negative | 20 | 1 | |||
Positive | 117 | 2.584 | |||
HER2 | 0.314–5.272 | 0.726 | |||
Negative | 105 | 1 | |||
Positive | 32 | 1.286 | |||
Histologic grade | 0.302–9.010 | 0.564 | |||
I+II | 122 | 1 | |||
III | 15 | 1.649 | |||
APE1 expression | 0.039–0.962 | 0.045 | |||
Low | 32 | 1 | |||
High | 105 | 0.193 |